These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 20228225)

  • 21. CXCR3 is involved in tubulointerstitial injury in human glomerulonephritis.
    Segerer S; Banas B; Wörnle M; Schmid H; Cohen CD; Kretzler M; Mack M; Kiss E; Nelson PJ; Schlöndorff D; Gröne HJ
    Am J Pathol; 2004 Feb; 164(2):635-49. PubMed ID: 14742268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infiltrating CD8+ T cells in oral lichen planus predominantly express CCR5 and CXCR3 and carry respective chemokine ligands RANTES/CCL5 and IP-10/CXCL10 in their cytolytic granules: a potential self-recruiting mechanism.
    Iijima W; Ohtani H; Nakayama T; Sugawara Y; Sato E; Nagura H; Yoshie O; Sasano T
    Am J Pathol; 2003 Jul; 163(1):261-8. PubMed ID: 12819030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of interferon-gamma- inducible protein-10 and its receptor CXCR3 in chronic pancreatitis.
    Singh L; Bakshi DK; Majumdar S; Vasishta RK; Arora SK; Wig JD
    Pancreatology; 2007; 7(5-6):479-90. PubMed ID: 17912012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated serum levels of the CXCR3 chemokine ITAC are associated with the development of transplant coronary artery disease.
    Kao J; Kobashigawa J; Fishbein MC; MacLellan WR; Burdick MD; Belperio JA; Strieter RM
    Circulation; 2003 Apr; 107(15):1958-61. PubMed ID: 12695288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CXCL9 and 11 in patients with pulmonary sarcoidosis: a role of alveolar macrophages.
    Nishioka Y; Manabe K; Kishi J; Wang W; Inayama M; Azuma M; Sone S
    Clin Exp Immunol; 2007 Aug; 149(2):317-26. PubMed ID: 17550373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy.
    Tokunaga R; Zhang W; Naseem M; Puccini A; Berger MD; Soni S; McSkane M; Baba H; Lenz HJ
    Cancer Treat Rev; 2018 Feb; 63():40-47. PubMed ID: 29207310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular characterization of the chemokine receptor CXCR3: evidence for the involvement of distinct extracellular domains in a multi-step model of ligand binding and receptor activation.
    Xanthou G; Williams TJ; Pease JE
    Eur J Immunol; 2003 Oct; 33(10):2927-36. PubMed ID: 14515277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recruitment and proliferation of T lymphocytes is supported by IFNgamma- and TNFalpha-activated human osteoblasts: Involvement of CD54 (ICAM-1) and CD106 (VCAM-1) adhesion molecules and CXCR3 chemokine receptor.
    Lisignoli G; Toneguzzi S; Piacentini A; Cristino S; Cattini L; Grassi F; Facchini A
    J Cell Physiol; 2004 Mar; 198(3):388-98. PubMed ID: 14755544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Distinct Roles of CXCR3 Variants and Their Ligands in the Tumor Microenvironment.
    Reynders N; Abboud D; Baragli A; Noman MZ; Rogister B; Niclou SP; Heveker N; Janji B; Hanson J; Szpakowska M; Chevigné A
    Cells; 2019 Jun; 8(6):. PubMed ID: 31216755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential expression of the CXCR3 ligands in chronic hepatitis C virus (HCV) infection and their modulation by HCV in vitro.
    Helbig KJ; Ruszkiewicz A; Lanford RE; Berzsenyi MD; Harley HA; McColl SR; Beard MR
    J Virol; 2009 Jan; 83(2):836-46. PubMed ID: 18987152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of JAK Inhibitors on Release of CXCL9, CXCL10 and CXCL11 from Human Airway Epithelial Cells.
    Fenwick PS; Macedo P; Kilty IC; Barnes PJ; Donnelly LE
    PLoS One; 2015; 10(6):e0128757. PubMed ID: 26090665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of chemokine receptor CXCR4 expression by transforming growth factor-β1 in human basal cell carcinoma cells.
    Chu CY; Sheen YS; Cha ST; Hu YF; Tan CT; Chiu HC; Chang CC; Chen MW; Kuo ML; Jee SH
    J Dermatol Sci; 2013 Nov; 72(2):123-33. PubMed ID: 23856244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CXCR3 requires tyrosine sulfation for ligand binding and a second extracellular loop arginine residue for ligand-induced chemotaxis.
    Colvin RA; Campanella GS; Manice LA; Luster AD
    Mol Cell Biol; 2006 Aug; 26(15):5838-49. PubMed ID: 16847335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Computational Study of C-X-C Chemokine Receptor (CXCR)3 Binding with Its Natural Agonists Chemokine (C-X-C Motif) Ligand (CXCL)9, 10 and 11 and with Synthetic Antagonists: Insights of Receptor Activation towards Drug Design for Vitiligo.
    Aguilera-Durán G; Romo-Mancillas A
    Molecules; 2020 Sep; 25(19):. PubMed ID: 32992956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The CXCR3-CXCL11 signaling axis mediates macrophage recruitment and dissemination of mycobacterial infection.
    Torraca V; Cui C; Boland R; Bebelman JP; van der Sar AM; Smit MJ; Siderius M; Spaink HP; Meijer AH
    Dis Model Mech; 2015 Mar; 8(3):253-69. PubMed ID: 25573892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IL-18 enhances IFN-gamma-induced production of CXCL9, CXCL10, and CXCL11 in human keratinocytes.
    Kanda N; Shimizu T; Tada Y; Watanabe S
    Eur J Immunol; 2007 Feb; 37(2):338-50. PubMed ID: 17274000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes.
    Kawada K; Sonoshita M; Sakashita H; Takabayashi A; Yamaoka Y; Manabe T; Inaba K; Minato N; Oshima M; Taketo MM
    Cancer Res; 2004 Jun; 64(11):4010-7. PubMed ID: 15173015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colon carcinoma cells induce CXCL11-dependent migration of CXCR3-expressing cytotoxic T lymphocytes in organotypic culture.
    Berencsi K; Meropol NJ; Hoffman JP; Sigurdson E; Giles L; Rani P; Somasundaram R; Zhang T; Kalabis J; Caputo L; Furth E; Swoboda R; Marincola F; Herlyn D
    Cancer Immunol Immunother; 2007 Mar; 56(3):359-70. PubMed ID: 16783574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conformational analysis of the human chemokine receptor CXCR3.
    Raucci R; Polo A; Budillon A; Colonna G; Costantini S
    Mol Immunol; 2017 Dec; 92():76-86. PubMed ID: 29054054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CXCR3 and CCR5 chemokines in induced sputum from patients with COPD.
    Costa C; Rufino R; Traves SL; Lapa E Silva JR; Barnes PJ; Donnelly LE
    Chest; 2008 Jan; 133(1):26-33. PubMed ID: 17925429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.